Prenatal Screening for Cystic Fibrosis Carriers: An Economic Evaluation

This publication has 48 references indexed in Scilit:

• Justifying Prenatal Screening and Genetic Amniocentesis Programs by Cost-Effectiveness Analyses
  Medical Decision Making, 1996
• Prenatal screening for cystic fibrosis: 5 years' experience reviewed
  The Lancet, 1996
• Stepwise or couple antenatal carrier screening for cystic fibrosis?: women's preferences and willingness to pay.
  Journal of Medical Genetics, 1995
• Screening for carriers of cystic fibrosis through primary health care services.
  BMJ, 1991
• Services for thalassaemia as a model for cost‐benefit analysis of genetics services
  Journal of Inherited Metabolic Disease, 1991
• Measuring the benefits of screening for open neural tube defects.
  Journal of Epidemiology and Community Health, 1982
• The ‘abnormal’ screening serum thyroxine (T4): Analysis of physician response, outcome, cost and health effectiveness
  Journal of Chronic Diseases, 1981
• A cost-benefit analysis of prenatal detection of down syndrome and neural tube defects in older mothers
  American Journal of Medical Genetics, 1981
• Estrogen Use in Postmenopausal Women — Costs, Risks, and Benefits
  New England Journal of Medicine, 1980
• HUMAN BENEFITS AND COSTS OF A NATIONAL SCREENING PROGRAMME FOR NEURAL-TUBE DEFECTS
  The Lancet, 1978